LAVIPHARM S.A. NA EO 1 (BXA0) — Defensive Interval Ratio
LAVIPHARM S.A. NA EO 1 (BXA0) has a Defensive Interval Ratio of 146 days as of December 2024. Defensive assets of €15.61 Million (cash €-, short-term investments €-, receivables €15.61 Million) cover 146 days of daily cash needs of €107.19K/day. Check LAVIPHARM S.A. NA EO 1 (BXA0) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LAVIPHARM S.A. NA EO 1 Defensive Interval Ratio (2021–2024)
This chart shows how LAVIPHARM S.A. NA EO 1's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 146 days, meaning defensive assets of €15.61 Million can fund 146 days of operations without new revenue. Also explore LAVIPHARM S.A. NA EO 1 (BXA0) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for LAVIPHARM S.A. NA EO 1 (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for LAVIPHARM S.A. NA EO 1 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LAVIPHARM S.A. NA EO 1 (BXA0) total market value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 146 days | €15.61 Million | €107.19K/day | €- | €- | ▼ -76 days |
| 2023 | 221 days | €21.70 Million | €98.08K/day | €- | €3.00K | ▲ +85 days |
| 2022 | 137 days | €17.13 Million | €125.32K/day | €- | €1.00K | ▼ -3 days |
| 2021 | 139 days | €15.66 Million | €112.51K/day | €- | €- | — |